Social life
Former members of the Biotherapy team
Houda DJERIR
Houda completed her PhD thesis in the laboratory, entitled: “Stellate cells: therapeutic target for hepatic fibrosis: discovery of the stellate cell hypertrophy/hepatic fibrosis association: RNA interference therapeutic strategies” under the supervision of Virginie ESCRIOU and co-supervised by Céline HOFFMANN. She defended her thesis on November 19, 2020, and since February 2021 has been a post-doctoral fellow at the Institut Curie in the Cancer, Heterogeneity, Instability and Plasticity – CHIP unit (U830).
Further information: Houda’s thesis
Rita DACLAT
Rita completed a post-doctoral fellowship as part of the ANR FIBROTHER project coordinated by Céline HOFFMANN from December 2019 to May 2022. Rita worked on the identification of molecular targets in a mouse model of hepatic fibrosis and studied molecular target silencing by siRNA lipoplexes both in vitro and in vivo. Since January 2023, Rita has been a Clinical Research Associate at the Hôpital Européen Georges Pompidou.
Danielle Campiol ARRUDA
Danielle Campiol Arruda completed a post-doctorate as part of the CAPES-COFECUB-funded NARNI project coordinated by Virginie ESCRIOU and Grace GOSMAN (Porto Alègre, Brazil) from April 2017 to July 2018. Danielle worked on the formulation of siRNAs in the form of lipid and hybrid nanoparticles. Since September 2019, Danielle has been a lecturer at ISPB-Faculté de Pharmacie, Université Claude Bernard Lyon 1.
À lire aussi

UTCBS takes part in the Faculty of Pharmacy Scientific Day
UTCBS takes part in the Faculty of Pharmacy Scientific Day

Job offer : Two-year Postdoctoral Position. Project: FunkNano4Cancer – Functionalisation of nanoparticles for improved diagnostics and anti-cancer efficacy
Job offer : Two-year Postdoctoral Position. Project: FunkNano4Cancer – Functionalisation of nanoparticles for improved diagnostics and anti-cancer efficacy.

1st meeting on Lipid Nanoparticles for delivery
Nathalie Mignet and her team, in association with the Société Française de Nanomédecine, are organizing the 1st meeting on Lipid Nanoparticles for RNA delivery on Thursday April 3, 2025 at the Faculté de Pharmacie in Paris.

Nathalie Mignet, at the “advances in nanomedicine” international conference
The international conference “advances in nanomedicine” organized by the editorial office of the journal Precision Nanomedecine and the Kalinga Institute in Bhubaneswar, Odisha, India, brought together the leading names in nanomedicine, Lou Balogh, editor-in-chief of...